Results 221 to 230 of about 1,440,519 (266)

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Exploring the methodological quality and risk of bias in 200 systematic reviews: A comparative study of ROBIS and AMSTAR-2 tools. [PDF]

open access: yesRes Synth Methods
Lunny C   +40 more
europepmc   +1 more source

Maternal early warning scores shown to be methodologically weak and at high risk of bias. [PDF]

open access: yesJ Clin Epidemiol
Chester-Jones M   +10 more
europepmc   +1 more source

Who is at risk of bias?

open access: yes
Altenmüller, Marlene Sophie   +1 more
openaire   +1 more source

Risk of Bias in Network Meta-Analysis (RoB NMA) tool.

open access: yesBMJ
Lunny C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy